Breakthrough Breast Cancer
  • Skip to content
The Breakthrough Research Centre supports a programme of cutting edge biological research that ultimately aims to eradicate breast cancer
  • Home |
  • Vacancies |
  • News & Events |
  • Contact Us
  • Research Centre
  • Units & Programmes
  • Population Studies
  • Clinical Trials
  • Strategy & Funding
  • In this section
    • History
    • The Director
    • Research Teams
      • Tumour Biology
        • Projects
    • Scientific Support
    • Contact Us

Tumour Angiogenesis Group

  • Print it
  • Share it
  • Back to top
  • Facebook
  • Twitter
  • Digg
  • Delicious
  • Google

Email it

Your message will be:

Thought you might be interested in this page on Breakthrough Breast Cancer.

Other projects

  • The role of VEGFR2 trafficking and signalling in angiogenesis
  • Role of the tumour microenvironment in resistance to angiogenesis inhibitors
  • Understanding the effects of anti-angiogenic drugs on tumour angiogenesis and tumour growth

ICR logo

  • The Research Centre

    • History
    • The Director
    • Research Teams
    • Scientific Support
    • Contact Us
  • Units & Programmes

    • Edinburgh
    • Manchester
    • King's College London
    • Clinician Scientist
  • Units & Programmes

    • Edinburgh
    • Manchester
    • King's College London
    • Clinician Scientist
  • Clinical Trials

    • ACU.FATIGUE Trial
    • PARP Inhibitor Trial
    • The BRCA trial
    • Triple Negative Trial
  • Strategy & Funding

    • How we fund research
    • Guidance for our Researchers
    • Open Access
  • Privacy |
  • Terms & Conditions |
  • Contact Us

© Breakthrough Breast Cancer is a charity registered in England & Wales (No. 1062636) & Scotland (No. SC039058).

Company limited by guarantee registered in England & Wales (No. 2848982).

  • Site by Torchbox